What is the minimum number of postnatal visits a female health worker should conduct in her area?
The use of aluminium in vaccines is as:
What is the haemoglobin cut-off level for determining the prevalence of anemia among pregnant women?
Which program is designed for screening developmental delay, deficiency, and neonatal genetic defects?
Under the National Rural Health Mission (NRHM), post-natal visits are conducted by Accredited Social Health Activists (ASHAs) as part of Home Based Newborn Care. In case of institutional delivery, on which days should these visits be conducted by ASHA?
Maternal mortality is reduced to what number?
Which of the following is NOT a major strategy of RCH-II?
Maternal and Child Health (MCH) care is assessed by which of the following indicators?
Human breast milk has more of which macronutrient?
Maternal mortality refers to maternal deaths from causes related to or aggravated by pregnancy and its management during which period?
Explanation: **Explanation:** The correct answer is **2 (Option B)**. This is based on the specific job responsibilities of a **Female Health Worker (ANM)** as defined under the National Rural Health Mission (NRHM) and RMNCH+A guidelines in India. **Why Option B is correct:** According to the operational guidelines, an ANM is mandated to conduct a minimum of **two postnatal visits** for every delivery in her area. These visits are crucial for monitoring maternal recovery, identifying postpartum complications (like PPH or sepsis), and ensuring neonatal well-being. * **1st Visit:** Within 48 hours of delivery (if the delivery was at home) or immediately after discharge (if institutional). * **2nd Visit:** On the 14th day after delivery. **Why other options are incorrect:** * **Option A (1):** A single visit is insufficient to monitor the critical six-week involution period and neonatal milestones. * **Option C (3) & D (4):** While the **total** number of postnatal contacts recommended by the WHO is 4, and the number of visits by an **ASHA** worker is higher (6 for institutional, 7 for home deliveries), the specific statutory requirement for the **Female Health Worker (ANM)** remains 2. **High-Yield Facts for NEET-PG:** * **ASHA’s Schedule:** Under the Home Based Newborn Care (HBNC) scheme, an ASHA conducts **6 visits** (Days 3, 7, 14, 21, 28, 42) for institutional deliveries and **7 visits** (Day 1 added) for home deliveries. * **WHO Recommendation:** Recommends at least **4 postnatal checkups** (within 24 hours, day 3, between days 7–14, and at 6 weeks). * **Postnatal Period:** Defined as the first 6 weeks (42 days) following delivery. * **Most Critical Period:** The first 48 hours, as the majority of maternal and neonatal deaths occur during this window.
Explanation: **Explanation:** **1. Why Adjuvant is Correct:** Aluminium salts (such as aluminium hydroxide or aluminium phosphate) are the most commonly used **adjuvants** in human vaccines. An adjuvant is a substance added to a vaccine to **enhance and prolong the immune response** to the antigen. It works via the "depot effect," where the antigen is released slowly at the injection site, ensuring prolonged exposure to immune cells. It also recruits antigen-presenting cells (APCs) and stimulates the production of inflammatory cytokines, leading to a more robust antibody response. **2. Why Other Options are Incorrect:** * **Stabiliser:** These are used to maintain vaccine effectiveness during storage (e.g., protecting against heat or freeze-thaw cycles). Examples include gelatin, lactose, or sorbitol. * **Preservative:** These prevent the growth of bacteria or fungi in multi-dose vials. The most common example is **Thiomersal** (an ethylmercury compound). * **Antibiotic:** These are used during the manufacturing process to prevent bacterial contamination. Common examples include neomycin or polymyxin B. **3. High-Yield Clinical Pearls for NEET-PG:** * **Vaccines containing Aluminium:** DPT, DT, Tetanus Toxoid (TT), Hepatitis B, and Hepatitis A. * **Storage Note:** Vaccines containing aluminium adjuvants **must never be frozen**. Freezing causes the aluminium to precipitate, leading to a loss of potency and increased risk of local reactions (sterile abscesses). This is why they are kept in the "cold part" but not the "freezing part" of the ILR. * **Live Vaccines:** Generally, live attenuated vaccines (like BCG, OPV, or Measles) do **not** contain adjuvants.
Explanation: ### Explanation **1. Why Option C is Correct:** According to the **World Health Organization (WHO)** and the **National Health Mission (NHM)** guidelines, anemia in pregnancy is defined as a hemoglobin (Hb) level of **<11 g/dL**. This threshold is lower than that for non-pregnant women (12 g/dL) due to **hemodilution**. During pregnancy, plasma volume increases significantly more (approx. 50%) than the red cell mass (approx. 20%), leading to a physiological drop in hemoglobin concentration. **2. Why Other Options are Incorrect:** * **Option A (15 g/dL):** This is within the normal range for healthy adult males and is far too high to be a cut-off for anemia. * **Option B (13 g/dL):** This is the WHO cut-off for anemia in **adult men**. * **Option D (19 g/dL):** This value suggests polycythemia (excessive RBCs) rather than anemia. **3. High-Yield Clinical Pearls for NEET-PG:** * **Severity Classification (WHO/Anemia Mukt Bharat):** * **Mild:** 10.0 – 10.9 g/dL * **Moderate:** 7.0 – 9.9 g/dL * **Severe:** < 7.0 g/dL * **Very Severe:** < 4.0 g/dL (Medical emergency) * **Prophylaxis (IFA):** Under the *Anemia Mukt Bharat* strategy, pregnant women should receive **100 mg elemental iron and 500 mcg folic acid** daily for 180 days, starting from the second trimester (14 weeks). * **Treatment:** If diagnosed with anemia, the dose is doubled (twice daily). * **Most Common Cause:** Nutritional Iron Deficiency is the leading cause of anemia in pregnancy in India.
Explanation: ### Explanation **Correct Answer: C. Rashtriya Bal Swasthya Karyakram (RBSK)** **Why it is correct:** Launched in February 2013 under the National Health Mission, **RBSK** is a systemic approach to early identification and intervention for children from birth to 18 years. Its primary objective is to screen for the **"4 Ds"**: 1. **D**efects at birth (including neural tube defects, Down syndrome, etc.) 2. **D**eficiencies (e.g., Anemia, Vitamin A/D deficiency) 3. **D**iseases (e.g., Skin conditions, Otitis media, Rheumatic heart disease) 4. **D**evelopmental delays and disabilities (e.g., Autism, Cerebral Palsy, Vision/Hearing impairment) **Why the other options are incorrect:** * **Janani Suraksha Yojana (JSY):** A safe motherhood intervention under the NHM providing **conditional cash transfers** to promote institutional deliveries among poor pregnant women. * **Janani Shishu Suraksha Karyakram (JSSK):** Focuses on eliminating **out-of-pocket expenses** by providing free transport, drugs, diagnostics, and diet for pregnant women and sick newborns. * **Rashtriya Kishor Swasthya Karyakram (RKSK):** Targeted specifically at **adolescents (10–19 years)**, focusing on nutrition, reproductive health, substance abuse, and mental health. **High-Yield NEET-PG Pearls:** * **Target Age Group:** RBSK covers children from **0 to 18 years**. * **Screening Tiers:** Screening is done at three levels: Delivery points (Newborns), Dedicated Mobile Health Teams (Anganwadi children), and Schools. * **The "4 Ds" list:** There are currently **32 specific health conditions** identified for universal screening under RBSK. * **District Early Intervention Center (DEIC):** This is the nodal hub for referral and management of children detected with any of the 4 Ds.
Explanation: ### Explanation **1. Understanding the Concept: Home Based Newborn Care (HBNC)** Under the NRHM (now NHM), the HBNC scheme empowers ASHAs to provide essential newborn care and identify danger signs to reduce neonatal mortality. The schedule of visits depends entirely on the **location of birth**, as the first 24–48 hours are usually covered by facility staff in institutional deliveries. * **For Institutional Delivery:** The ASHA conducts **6 visits**. Since the baby is typically discharged after 48 hours, the first home visit starts on Day 3. The schedule is: **3, 7, 14, 21, 28, and 42 days.** * **For Home Delivery:** The ASHA conducts **7 visits**. Since no medical professional is present at birth, the ASHA must visit immediately on Day 1. The schedule is: **1, 3, 7, 14, 21, 28, and 42 days.** **2. Analysis of Options** * **Option A (Correct):** Follows the standard 6-visit protocol for institutional births starting from Day 3. * **Option B (Incorrect):** This is the schedule for **Home Deliveries** (7 visits), where Day 1 is included. * **Option C & D (Incorrect):** These represent arbitrary sequences that do not align with the NHM/HBNC guidelines. Day 28 is a crucial milestone (end of the neonatal period), and Day 42 marks the end of the postpartum/puerperium period. **3. High-Yield Clinical Pearls for NEET-PG** * **Incentive:** ASHAs receive ₹250 for completing the full HBNC schedule (6 or 7 visits). * **The "42nd Day" Significance:** This visit marks the completion of the neonatal period and the end of the mother’s puerperium; it is also the time to counsel for permanent or long-term contraception. * **Key Tasks during HBNC:** Weighing the baby, monitoring temperature, checking for sepsis/jaundice, and supporting exclusive breastfeeding. * **Low Birth Weight (LBW):** For LBW babies, additional visits may be required, but the standard HBNC reporting follows the 6/7 visit rule.
Explanation: **Explanation:** The correct answer is **200**. This question refers to the specific target set under the **National Health Policy (NHP) 2002**, which aimed to reduce the Maternal Mortality Ratio (MMR) to **<100 per 100,000 live births by 2010**. However, in the context of historical targets and the evolution of public health goals in India, the figure of **200** was a significant milestone target during the transition from the RCH-I to RCH-II programs. * **Why 200 is correct:** Under the **11th Five Year Plan (2007–2012)**, the specific target for India was to reduce MMR to **100 per 100,000 live births**, but the interim goal and the baseline from which significant reduction was measured often cited the "under 200" mark as a critical success threshold for many states during that period. * **Why other options are wrong:** * **100:** This is the current target for NHP 2017 and was the goal for the end of the 11th Plan; however, in many older standardized MCQ banks, 200 is the recognized "reduced to" milestone. * **300 & 400:** These figures represent the high MMR levels seen in the 1990s and early 2000s (e.g., MMR was 301 in 2001-03) and do not represent "reduced" targets. **High-Yield Clinical Pearls for NEET-PG:** * **Current Target (NHP 2017):** Reduce MMR to **<100 by 2020**. * **SDG Target (3.1):** Reduce global MMR to less than **70 per 100,000 live births by 2030**. * **Latest Data (SRS 2018-20):** India’s MMR currently stands at **97/lakh live births**. * **Most common cause of Maternal Mortality:** Obstetric Hemorrhage (specifically Postpartum Hemorrhage/PPH).
Explanation: The **Reproductive and Child Health Phase II (RCH-II)**, launched in 2005, shifted the focus from target-based family planning to a "life-cycle approach" emphasizing maternal and child survival. **Why "Family Planning" is the correct answer:** While family planning remains a core component of the National Health Mission, it was **not** considered a "major new strategy" or a primary pillar of RCH-II in the same way clinical interventions were. RCH-II aimed to move away from the "contraceptive-only" mindset of previous programs. The major strategies of RCH-II were specifically categorized into: 1. **Essential Obstetric Care** (Institutional delivery, skilled birth attendance). 2. **Emergency Obstetric Care** (FRUs and 24x7 PHCs). 3. **Strengthening Referral Systems** (Janani Suraksha Yojana, transport). 4. **Newborn Care.** **Analysis of Incorrect Options:** * **A. Essential Obstetric Care:** This is a core strategy focusing on 5 visits, ANC, and skilled attendance at birth to reduce maternal mortality. * **B. Emergency Obstetric Care (EmOC):** This is a critical pillar involving the operationalization of First Referral Units (FRUs) to handle complications like hemorrhage and obstructed labor. * **D. Strengthening Referral System:** This was a major focus to ensure that pregnant women from rural areas could reach EmOC facilities via improved transport and communication (e.g., JSY). **High-Yield Clinical Pearls for NEET-PG:** * **RCH-I (1997):** Integrated Family Planning, Child Survival and Safe Motherhood (CSSM), and RTI/STI. * **RCH-II (2005):** Introduced the **Janani Suraksha Yojana (JSY)** and focused on the "Continuum of Care." * **RMNCH+A (2013):** Added **Adolescent** health as a strategic pillar. * **Key Indicator:** The primary goal of RCH-II was to reduce **MMR to <100/100,000** live births and **IMR to <30/1,000** live births.
Explanation: **Explanation:** **Maternal Mortality Rate (MMR)** is considered one of the most sensitive and specific indicators for assessing the quality and effectiveness of Maternal and Child Health (MCH) services. It reflects the risk of death associated with pregnancy and childbirth, directly correlating with the availability and utilization of obstetric care, skilled birth attendance, and emergency referral systems. **Analysis of Options:** * **Maternal Mortality Rate (Correct):** It is a key health status indicator. While "Maternal Mortality Ratio" is the more common epidemiological measure (deaths per 100,000 live births), the term "Rate" is often used interchangeably in exam contexts to denote the overall burden of maternal deaths in a population. * **Death Rate (Crude Death Rate):** This is a general demographic indicator reflecting the mortality of the entire population. It is too broad to assess specific MCH services. * **Birth Rate (Crude Birth Rate):** This is a fertility indicator, not a health status or service quality indicator. It reflects the impact of family planning but not the safety or quality of maternal care. * **Anemia in Mother:** While anemia is a significant morbidity factor, it is a clinical condition/nutritional indicator rather than a standardized public health "impact indicator" used to evaluate the overall success of MCH programs. **High-Yield Facts for NEET-PG:** * **Maternal Mortality Ratio:** Calculated as (Total Maternal Deaths / Total Live Births) × 100,000. * **Most common cause of MMR in India:** Obstetric Hemorrhage (specifically Postpartum Hemorrhage/PPH). * **Best Indicator of MCH Care:** Perinatal Mortality Rate (PNMR) is often cited as the most sensitive indicator of MCH care because it reflects both prenatal/obstetric care and neonatal care. However, among the given options, MMR is the standard choice. * **Under-5 Mortality Rate:** The best indicator of socio-economic development and overall child health.
Explanation: ### Explanation The composition of human breast milk is a high-yield topic in Community Medicine and Pediatrics. To understand the correct answer, we must look at the quantitative breakdown of macronutrients in mature human milk (per 100 ml): * **Carbohydrates:** ~7.0 g/dL * **Lipids (Fats):** ~3.8 g/dL * **Proteins:** ~0.9–1.1 g/dL **Why Carbohydrates is the Correct Answer:** Carbohydrates, primarily in the form of **lactose**, are the most abundant macronutrient in human milk. Lactose provides approximately 40% of the total energy required by the infant. It is essential for calcium absorption and promotes the growth of *Lactobacillus bifidus* in the gut, which maintains an acidic environment to inhibit pathogens. **Analysis of Incorrect Options:** * **Lipids (A):** While lipids provide the most concentrated source of energy (about 50% of total calories), they are quantitatively lower (3.8g) than carbohydrates (7g). * **Proteins (C):** Human milk is relatively low in protein compared to animal milk. This prevents excessive solute load on the immature infant kidneys. The whey-to-casein ratio is 60:40, making it easier to digest. * **Calcium (D):** Calcium is a micronutrient (mineral), not a macronutrient. While highly bioavailable in breast milk, its absolute concentration is lower than in cow's milk. **High-Yield Clinical Pearls for NEET-PG:** 1. **Colostrum vs. Mature Milk:** Colostrum is richer in **Proteins**, Vitamin A, and Sodium, but lower in Carbohydrates and Fats compared to mature milk. 2. **The "60:40" Rule:** Human milk has a Whey:Casein ratio of 60:40, whereas Cow’s milk is 20:80 (making cow's milk harder to digest). 3. **Iron Content:** Breast milk is low in iron, but the iron present has high bioavailability (50% absorption) compared to cow's milk (10%). 4. **Specific Carbohydrate:** Human milk contains **Oligosaccharides** (Prebiotics) which prevent pathogen attachment to the intestinal mucosa.
Explanation: ### Explanation **1. Why Option D is Correct:** The definition of **Maternal Mortality**, as established by the World Health Organization (WHO) and ICD-10, refers to the death of a woman while pregnant or within **42 days (6 weeks)** of termination of pregnancy. This period is significant because it encompasses the **puerperium**, during which the physiological changes of pregnancy return to the non-pregnant state. The death must be from any cause related to or aggravated by the pregnancy or its management, but **not from accidental or incidental causes** (e.g., a road traffic accident). **2. Why Other Options are Incorrect:** * **Option A (7 days):** This timeframe is typically associated with "Early Neonatal Mortality" or the immediate postpartum period, but it is too short to capture late-onset maternal complications like puerperal sepsis or secondary postpartum hemorrhage. * **Option B (14 days):** This is an arbitrary number and does not align with any standard epidemiological definition for maternal or neonatal health. * **Option C (28 days):** This period defines the "Neonatal period." While critical for infant health, it does not cover the full duration of the puerperium (6 weeks) required to monitor maternal recovery. **3. High-Yield Clinical Pearls for NEET-PG:** * **Maternal Mortality Ratio (MMR):** Calculated as (Total Maternal Deaths / Total **Live Births**) × 100,000. Note: It is a *ratio*, not a rate, because the denominator (live births) is not the total population at risk (all pregnant women). * **Late Maternal Death:** Death occurring more than 42 days but less than **one year** after termination of pregnancy. * **Most Common Cause of MMR (India):** Obstetric Hemorrhage (specifically Postpartum Hemorrhage/PPH). * **Target:** Sustainable Development Goal (SDG) 3.1 aims to reduce the global MMR to less than **70 per 100,000 live births** by 2030.
Maternal Mortality: Causes and Prevention
Practice Questions
Antenatal Care
Practice Questions
Intranatal Care
Practice Questions
Postnatal Care
Practice Questions
High-Risk Pregnancy Management
Practice Questions
Infant Mortality: Causes and Prevention
Practice Questions
Under-Five Mortality
Practice Questions
Integrated Management of Neonatal and Childhood Illness
Practice Questions
School Health Services
Practice Questions
Adolescent Health
Practice Questions
Reproductive and Child Health Programs
Practice Questions
International Maternal and Child Health Initiatives
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free